{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T20:21:26Z","timestamp":1784751686157,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.numecd.2026.104862","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T07:11:56Z","timestamp":1783494716000},"page":"104862","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Remnant cholesterol and incident metabolic syndrome: evidence from a prospective cohort with emphasis on individuals with normal triglyceride levels"],"prefix":"10.1016","author":[{"given":"Siying","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8456-8515","authenticated-orcid":false,"given":"Yuzhang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2026.104862_bib1","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1210\/er.2008-0024","article-title":"The metabolic syndrome","volume":"29","author":"Cornier","year":"2008","journal-title":"Endocr Rev"},{"key":"10.1016\/j.numecd.2026.104862_bib2","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The metabolic syndrome","volume":"365","author":"Eckel","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2026.104862_bib3","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of insulin action and insulin resistance","volume":"98","author":"Petersen","year":"2018","journal-title":"Physiol Rev"},{"key":"10.1016\/j.numecd.2026.104862_bib4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.tem.2011.04.007","article-title":"Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance","volume":"22","author":"Choi","year":"2011","journal-title":"Trends Endocrinol Metabol"},{"key":"10.1016\/j.numecd.2026.104862_bib5","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","article-title":"Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the european Atherosclerosis Society","volume":"42","author":"Ginsberg","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2026.104862_bib6","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.pharmthera.2013.11.008","article-title":"Remnant cholesterol as a cause of ischemic heart disease: evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment","volume":"141","author":"Varbo","year":"2014","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.numecd.2026.104862_bib7","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1016\/j.jacc.2020.10.008","article-title":"Remnant cholesterol, not LDL cholesterol, is associated with incident cardiovascular disease","volume":"76","author":"Casta\u00f1er","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2026.104862_bib8","article-title":"The role of systemic inflammation in remnant cholesterol associated cardiovascular risk: insights from the EPIC-Norfolk study","author":"Kraaijenhof","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.numecd.2026.104862_bib9","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1161\/CIRCULATIONAHA.113.003008","article-title":"Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation","volume":"128","author":"Varbo","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2026.104862_bib10","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.cmet.2021.09.001","article-title":"Cholesterol-induced toxicity: an integrated view of the role of cholesterol in multiple diseases","volume":"33","author":"Song","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/j.numecd.2026.104862_bib11","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.3390\/nu16193275","article-title":"Association between remnant cholesterol and metabolic syndrome among Chinese adults: chinese nutrition and health surveillance (2015-2017)","volume":"16","author":"Li","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.numecd.2026.104862_bib12","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/s40001-023-01369-z","article-title":"Association between remnant cholesterol, metabolic syndrome, and cardiovascular disease: post hoc analysis of a prospective national cohort study","volume":"28","author":"Jin","year":"2023","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.numecd.2026.104862_bib13","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s40200-025-01692-8","article-title":"Association between remnant cholesterol and metabolic syndrome beyond conventional lipid parameters in middle Age and elderly population: Bushehr Elderly Health (BEH) cohort","volume":"24","author":"Esmaeili","year":"2025","journal-title":"J Diabetes Metab Disord"},{"key":"10.1016\/j.numecd.2026.104862_bib14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/ije\/dys203","article-title":"Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS)","volume":"43","author":"Zhao","year":"2014","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.numecd.2026.104862_bib15","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1093\/eurheartj\/ehab293","article-title":"Directly measured vs. calculated remnant cholesterol identifies additional overlooked individuals in the general population at higher risk of myocardial infarction","volume":"42","author":"Varbo","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2026.104862_bib16","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"IDF Epidemiology Task Force Consensus Group. The metabolic syndrome--a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2026.104862_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2393","article-title":"Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls","volume":"338","author":"Sterne","year":"2009","journal-title":"Br Med J"},{"key":"10.1016\/j.numecd.2026.104862_bib18","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified poisson regression approach to prospective studies with binary data","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.numecd.2026.104862_bib19","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/sim.3841","article-title":"Dose-response analyses using restricted cubic spline functions in public health research","volume":"29","author":"Desquilbet","year":"2010","journal-title":"Stat Med"},{"key":"10.1016\/j.numecd.2026.104862_bib20","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1161\/CIRCULATIONAHA.109.192278","article-title":"Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association","volume":"119","author":"Hlatky","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2026.104862_bib21","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2026.104862_bib22","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1016\/j.immuni.2025.09.011","article-title":"Obesity, diabetes, and inflammation: pathophysiology and clinical implications","volume":"58","author":"Donath","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.numecd.2026.104862_bib23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41573-023-00822-2","article-title":"Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets","volume":"23","author":"Vande Walle","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.numecd.2026.104862_bib24","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1161\/CIRCRESAHA.118.311362","article-title":"NLRP3 inflammasome and the IL-1 pathway in atherosclerosis","volume":"122","author":"Grebe","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.numecd.2026.104862_bib25","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/CIRCRESAHA.123.321637","article-title":"Inflammasomes and atherosclerosis: a mixed picture","volume":"132","author":"Tall","year":"2023","journal-title":"Circ Res"},{"key":"10.1016\/j.numecd.2026.104862_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41569-022-00676-y","article-title":"Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia","author":"Bor\u00e9n","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.numecd.2026.104862_bib27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/eurheartj\/ehz785","article-title":"Clinical review on triglycerides","volume":"41","author":"Laufs","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2026.104862_bib28","article-title":"High remnant cholesterol level potentiates the development of hypertension","volume":"13","author":"Chen","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.numecd.2026.104862_bib29","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/s41440-023-01558-7","article-title":"Remnant cholesterol and risk of incident hypertension: a population-based prospective cohort study","volume":"47","author":"Guo","year":"2024","journal-title":"Hypertens Res"},{"key":"10.1016\/j.numecd.2026.104862_bib30","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12944-023-01915-y","article-title":"Association of remnant cholesterol with hypertension, type 2 diabetes, and their coexistence: the mediating role of inflammation-related indicators","volume":"22","author":"Wu","year":"2023","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.numecd.2026.104862_bib31","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1161\/01.CIR.97.25.2519","article-title":"Association of remnant Lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries","volume":"97","author":"Kugiyama","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2026.104862_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154766","article-title":"Insulin resistance, cardiovascular stiffening and cardiovascular disease","volume":"119","author":"Hill","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.numecd.2026.104862_bib33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12933-022-01554-0","article-title":"The role of remnant cholesterol beyond low-density lipoprotein cholesterol in diabetes mellitus","volume":"21","author":"Hu","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.numecd.2026.104862_bib34","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2337\/dc22-1550","article-title":"Remnant cholesterol is an independent predictor of type 2 diabetes: a nationwide population-based cohort Study","volume":"46","author":"Huh","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2026.104862_bib35","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1111\/dom.16383","article-title":"Changes in remnant cholesterol and the incidence of diabetes: results from two large prospective cohort studies","volume":"27","author":"Shao","year":"2025","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.numecd.2026.104862_bib36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41586-019-1797-8","article-title":"The integrative biology of type 2 diabetes","volume":"576","author":"Roden","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.numecd.2026.104862_bib37","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(09)60619-X","article-title":"Trajectories of glycemia, insulin sensitivity and insulin secretion preceding the diagnosis of type 2 diabetes: the whitehall II Study","volume":"373","author":"Tab\u00e1k","year":"2009","journal-title":"Lancet"},{"issue":"Suppl 3","key":"10.1016\/j.numecd.2026.104862_bib38","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.2337\/diabetes.53.suppl_3.S16","article-title":"Five stages of evolving beta-cell dysfunction during progression to diabetes","volume":"53","author":"Weir","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.numecd.2026.104862_bib39","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/eurheartj\/ehac822","article-title":"Elevated remnant cholesterol, plasma triglycerides, and cardiovascular and non-cardiovascular mortality","volume":"44","author":"Wadstr\u00f6m","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2026.104862_bib40","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.jacc.2022.03.384","article-title":"Elevated remnant cholesterol reclassifies risk of ischemic heart disease and myocardial infarction","volume":"79","author":"Doi","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2026.104862_bib41","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1038\/s41467-024-46686-x","article-title":"Elevated blood remnant cholesterol and triglycerides are causally related to the risks of cardiometabolic multimorbidity","volume":"15","author":"Zhao","year":"2024","journal-title":"Nat Commun"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475326003248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475326003248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T19:45:12Z","timestamp":1784749512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475326003248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":41,"alternative-id":["S0939475326003248"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2026.104862","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Remnant cholesterol and incident metabolic syndrome: evidence from a prospective cohort with emphasis on individuals with normal triglyceride levels","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2026.104862","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104862"}}